Xuzhen Yan

512 total citations
18 papers, 337 citations indexed

About

Xuzhen Yan is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Xuzhen Yan has authored 18 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Xuzhen Yan's work include Liver Disease Diagnosis and Treatment (10 papers), Liver physiology and pathology (9 papers) and Microbial metabolism and enzyme function (6 papers). Xuzhen Yan is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Liver physiology and pathology (9 papers) and Microbial metabolism and enzyme function (6 papers). Xuzhen Yan collaborates with scholars based in China, United States and Switzerland. Xuzhen Yan's co-authors include Aiting Yang, Hong You, Wei Chen, Jidong Jia, Anjian Xu, Wenshan Zhao, Min Cong, Ping Wang, Tao Huang and Tianhui Liu and has published in prestigious journals such as Hepatology, Scientific Reports and The FASEB Journal.

In The Last Decade

Xuzhen Yan

16 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuzhen Yan China	10	129	125	121	66	53	18	337
Eiko Saijou Japan	7	172 1.3×	83 0.7×	80 0.7×	47 0.7×	41 0.8×	10	376
Monika Pikiolek Switzerland	6	218 1.7×	62 0.5×	143 1.2×	154 2.3×	72 1.4×	6	453
Shuji Uematsu Japan	10	111 0.9×	107 0.9×	147 1.2×	60 0.9×	41 0.8×	14	358
Shuya Kaneko Japan	8	78 0.6×	42 0.3×	56 0.5×	59 0.9×	50 0.9×	32	261
Xueying Hou China	7	217 1.7×	89 0.7×	46 0.4×	30 0.5×	58 1.1×	14	371
Anal Desai United States	5	268 2.1×	58 0.5×	37 0.3×	60 0.9×	53 1.0×	5	412
Yeben Qian China	12	158 1.2×	50 0.4×	65 0.5×	44 0.7×	56 1.1×	24	334
Laura Kitto United Kingdom	4	62 0.5×	64 0.5×	70 0.6×	46 0.7×	26 0.5×	5	205
Anna Feren United States	7	154 1.2×	78 0.6×	117 1.0×	54 0.8×	92 1.7×	8	345

Countries citing papers authored by Xuzhen Yan

Since Specialization

Citations

This map shows the geographic impact of Xuzhen Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuzhen Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuzhen Yan more than expected).

Fields of papers citing papers by Xuzhen Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuzhen Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuzhen Yan. The network helps show where Xuzhen Yan may publish in the future.

Co-authorship network of co-authors of Xuzhen Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuzhen Yan. A scholar is included among the top collaborators of Xuzhen Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuzhen Yan. Xuzhen Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Yan, Xuzhen, Qi Han, Li Hong, et al.. (2025). ITGA8 deficiency in hepatic stellate cells attenuates CCl4-Induced liver fibrosis via suppression of COL11A1. Biochemical and Biophysical Research Communications. 756. 151522–151522.

Yan, Xuzhen, Qi Han, Yiwen Wang, et al.. (2025). Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis. Cellular and Molecular Gastroenterology and Hepatology. 20(2). 101637–101637.

Zhang, Ning, Congjun Li, Yameng Sun, et al.. (2025). Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation. Theranostics. 15(9). 4033–4053. 3 indexed citations

Zhang, Ning, Xiaoning Wu, Yameng Sun, et al.. (2024). Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling. JHEP Reports. 6(3). 101014–101014. 8 indexed citations

Wang, Zhaojia, et al.. (2024). Mitochondria-Associated Membranes in Aging and Senescence. Aging and Disease. 16(4). 2250–2272. 2 indexed citations

Zhang, Ning, Aiting Yang, Hong Li, et al.. (2024). Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal. Hepatology Communications. 8(4). 5 indexed citations

Han, Qi, Xuzhen Yan, Ning Zhang, et al.. (2023). Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism. Biochemical and Biophysical Research Communications. 682. 259–265. 2 indexed citations

Chen, Wei, Yameng Sun, Shuyan Chen, et al.. (2023). Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities. Hepatology. 78(4). 1118–1132. 15 indexed citations

Wang, Sihan, Heng Zhou, Wei Chen, et al.. (2023). CryoFIB milling large tissue samples for cryo-electron tomography. Scientific Reports. 13(1). 5879–5879. 11 indexed citations

10.

Yan, Xuzhen, Ning Zhang, Tao Huang, et al.. (2023). Selective inhibition of hepatic stellate cell and fibroblast-derived LOXL1 attenuates BDL- and Mdr2^−/−-induced cholestatic liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 325(6). G608–G621. 4 indexed citations

11.

Chen, Hui, et al.. (2022). Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis. Journal of Clinical and Translational Hepatology. 10(4). 577–588. 19 indexed citations

12.

Yang, Aiting, Xuzhen Yan, Hiroyuki Abé, et al.. (2022). Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis. Cellular and Molecular Gastroenterology and Hepatology. 15(4). 841–867. 70 indexed citations

13.

Yang, Aiting, Xuzhen Yan, Xu Fan, et al.. (2021). Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice. Hepatology International. 15(5). 1122–1135. 27 indexed citations

14.

Yang, Aiting, Xuzhen Yan, Hufeng Xu, et al.. (2021). Selective depletion of hepatic stellate cells‐specific LOXL1 alleviates liver fibrosis. The FASEB Journal. 35(10). e21918–e21918. 21 indexed citations

15.

Chen, Wei, Xiaoning Wu, Xuzhen Yan, et al.. (2019). Multitranscriptome analyses reveal prioritized genes specifically associated with liver fibrosis progression independent of etiology. American Journal of Physiology-Gastrointestinal and Liver Physiology. 316(6). G744–G754. 26 indexed citations

16.

Chen, Wei, Xuzhen Yan, Aiting Yang, et al.. (2019). miRNA-150-5p Promotes Hepatic Stellate Cell Proliferation and Sensitizes Hepatocyte Apoptosis During Liver Fibrosis. Epigenomics. 12(1). 53–67. 26 indexed citations

17.

Chen, Wei, Xuzhen Yan, Anjian Xu, et al.. (2019). Dynamics of elastin in liver fibrosis: Accumulates late during progression and degrades slowly in regression. Journal of Cellular Physiology. 234(12). 22613–22622. 30 indexed citations

18.

Zhao, Wenshan, Aiting Yang, Wei Chen, et al.. (2018). Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1129–1137. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact